International Journal of Clinical Oncology

Article	Citations
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer	71
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050	58
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)	52
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis	49
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis	46
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma	45
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study	37
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study	35
Aging, cancer, and antitumor immunity	34
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1	29
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan	29
Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperi	28
Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy	26
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis	26
Key promoters of tumor hallmarks	25
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan	25
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma	24
Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System	24
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma	24
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy	23
HER2-low breast cancer could be associated with an increased risk of brain metastasis	22
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data	22
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)	21
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review	21
Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy	21

Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer	21
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis	21
Frailty is associated with poor prognosis after resection for pancreatic cancer	20
The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis	20
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or	20
Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy	20
Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients	20
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study	19
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors	19
FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma	19
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis	19
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma	18
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic	18
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan	18
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases	17
Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults af	17
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study	16
The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis	16
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study	15
Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis	15
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy	15
Soft-tissue sarcoma in adolescents and young adults	15
Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic	15
The roles and limitations of bevacizumab in the treatment of ovarian cancer	15
TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway	15
Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma	15
Hereditary pancreatic cancer	15
A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center	14
Preoperative nutrition and exercise intervention in frailty patients with gastric cancer undergoing gastrectomy	14
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1	14
Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution	14
Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy	14
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy	14
Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer	14
A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG	13
LINC00943 is correlated with gastric cancer and regulates cancer cell proliferation and chemosensitivity via hsa-miR-101-3p	13
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary	13
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer	13
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma	13
Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study	13
Association between chronic kidney disease and mortality in stage IV cancer	13
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases	13
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study	12
Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer	12
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retro	12
Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study	12
The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer	12
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium	12
Jab1/Cops5: a promising target for cancer diagnosis and therapy	12
Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis	12

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA	12
HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients	12
Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study	12
Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer	12
The role of surgery in the treatment of metastatic bone tumor	12
The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer	12
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model	12
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib	12
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib	11
Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in	11
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2	11
Clinical characteristics and predictors of permanent stoma in rectal cancer patients underwent anterior resections: the value of preoperative prognostic nutritional index	11
Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study	11
General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis	11
Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer	11
Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma	11
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis	11
CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis	11
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score	11
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with	11
Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases	11
SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis	11
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis	10
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse	10
Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through MiR-138 and MiR-34c in gastric cancer cells	10
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis	10
Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan	10
Treatments for elderly cancer patients and reforms to social security systems in Japan	10
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study	10
Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis	10
Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study	10
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis	10
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes	10
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma	10
Epidemiology and survival outcomes of primary gastrointestinal melanoma: a SEER-based population study	10
A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer	10
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients	10
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)	10
Central statistical monitoring of investigator-led clinical trials in oncology	10
Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour	10
The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway	10
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience	9
A comparative examination of colorectal cancer burden in European Union, 1990–2019: Estimates from Global Burden of Disease 2019 Study	9
Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns	9
Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining	9
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs	9
Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study	9
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT	9
Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience	9
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study	9
Preoperative predictors of dysphagia after transoral surgery	9
Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review	9
Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer	9
YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2	9
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis	9
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study	9
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer	9
Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcome	9
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location	9
Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma	9
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)	9
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients	8
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review	8
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden	8
Serum zinc deficiency in patients after gastrectomy for gastric cancer	8
Preoperative iron status is a prognosis factor for stage II and III colorectal cancer	8
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketin	8
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801	8
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer	8
Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy	8
Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients	8
APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients	8
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer	8
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab	8
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib	8
Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera’s prognostic nutritional index	8
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study	8
Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan	8
A novel clinically-oriented classification of fine-needle aspiration cytology for salivary gland tumors: a 20-year retrospective analysis of 1175 patients	8
Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex	8

Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer	8
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study	7
Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan	7
Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma	7
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer	7
Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation	7
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy	7
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study	7
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma	7
Oncologic outcomes for patients with endometrial cancer who received minimally invasive surgery: a retrospective observational study	7
Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer	7
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis	7
Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body	7
Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer	7
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia	7
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis	7
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma	7
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospect	7
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective o	7
Prognostic significance of peritoneal cytology in low-risk endometrial cancer: comparison of laparoscopic surgery and laparotomy	7
Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence	7
Role of the DEK oncogene in the development of squamous cell carcinoma	7
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial	7
Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching	7
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer	7
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas	7
Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial	7
Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer	7
Adolescent and young adult brain tumors: current topics and review	6
Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression	6
Carcinogenesis and management of human papillomavirus-associated cervical cancer	6
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer	6
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048	6
Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study	6
Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up	6
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab	6
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors	6
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study	6
Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis	6
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research	6
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study	6
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis	6
Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database	6
Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors	6
Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial	6
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan	6
The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer	6
The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan	6
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?	6
Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis	6
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade	6
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study	6
Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy	6
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance	6
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan	6
Contributions of HOTAIR polymorphisms to the susceptibility of cancer	6
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis	6
The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study	6
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data	6
Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analy	6
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis	6
Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis	6
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents	6
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer	6
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma	6